Unibest
← Back to patent-cliff list

CAS 90-05-1

2-methoxyphenol

Codes: RANO-007, SILO-018, BOSE-001

Application context (from source-drug indications)

Angina pectorisRanolazineMyocardial infarctionRanolazineAmyotrophic lateral sclerosisRanolazineStable anginaRanolazineCrohn's diseaseRanolazineInflammatory bowel diseaseRanolazineBenign prostatic hyperplasiaSilodosinLower urinary tract symptomsSilodosinUrolithiasisSilodosinKidney stonesSilodosinContraceptive useSilodosinUrinary tract stonesSilodosin溃疡Bosentan HydratePulmonary arterial hypertensionBosentan HydratePulmonary hypertensionBosentan HydrateSystemic sclerosisBosentan Hydrate冠状血管痉挛Bosentan Hydrate大动脉炎Bosentan Hydrate

Source drugs (routes using this intermediate)

DrugTierExpiry
RanolazineTier C — Watch / trade-
SilodosinTier C — Watch / trade-
Bosentan HydrateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

SilodosinOriginator routesteps: 18total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.